M&A Healthcare Advisors Featured in Axial IB 2022 Annual Review

  • Home
  • /
  • Blog
  • /
  • Press
  • /
  • M&A Healthcare Advisors Featured in Axial IB 2022 Annual Review

M&A Healthcare Advisors has been an Axial IB Partner since our launch and we are proud to be featured in their 2022 annual review.

In 2022, Axial’s Investment Banking Partners brought 327 new transactions to market via Axial, resulting in 2,650 signed NDAs. Partners successfully closed 61 deals in the calendar year 2022, according to data shared with Axial.

Axial Partners, who were collectively featured 71 times across Axial’s League Tables and Industry Top 50 reports, represent less than 1% of active sell-side members on the Axial platform. They have each established a reputation for client quality, sell-side process effectiveness, and high close rates.

Congratulations to each of these lower middle market investment banks and M&A advisory firms for their dealmaking achievements in 2022.


More From M&A Healthcare Advisors

Understanding Working Capital and the True-Up Process in Healthcare M&A
Enhancing Enterprise Value: The Uses of a Quality of Earnings (QoE) Analysis for Maturing Businesses
Understanding Working Capital and the True-Up Process in Healthcare M&A
What Are the Stages of the Due Diligence Process?
Understanding Working Capital and the True-Up Process in Healthcare M&A
2025 Healthcare M&A Market Forecast: A MAHA Perspective
{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Get in touch

Name*
Email*
Message
0 of 350